clinical trial · NCT07223307
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Liver CancerIntrahepatic CholangiocarcinomaLiver MetastasesHCCMRI-guided adaptive stereotactic ablative body radiotherapy (SABR)
brief summary
Single arm unblinded study of simulation-free MRI-guided SABR with adaptive replanning in one session for treatment of patients with liver cancers
started
Jan 23, 2026
primary completion
Jan 1, 2030
completion
Jan 1, 2030
last updated
Feb 9, 2026
official title
Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol